Screening Program
  • Awarded Year
    2015
  • Awarded Amount
    $132,000
  • Disease
    Tuberculosis
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Mitsubishi Tanabe Pharma, The Global Alliance for TB Drug Development